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Abstract
Background: Intensive care unit (ICU) patients require dialysis catheters (DCs) for renal replacement therapy (RRT).
They carry a high risk of developing end-stage renal disease, and therefore their vascular access must be preserved.
Guidewire exchange (GWE) is often used to avoid venipuncture insertion (VPI) at a new site. However, the impact of
GWE on infection and dysfunction of DCs in the ICU is unknown. Our aim was to compare the effect of GWE and
VPI on DC colonization and dysfunction in ICU patients.
Methods: Using data from the ELVIS randomized controlled trial (RCT) (1496 ICU adults requiring DC for RRT or plasma
exchange) we performed a matched-cohort analysis. Cases were DCs inserted by GWE (n = 178). They were matched
with DCs inserted by VPI. Matching criteria were participating centre, simplified acute physiology score (SAPS) II +/-10,
insertion site (jugular or femoral), side for jugular site, and length of ICU stay before DC placement. We used a marginal
Cox model to estimate the effect of DC insertion (GWE vs. VPI) on DC colonization and dysfunction.
Results: DC colonization rate was not different between GWE-DCs and VPI-DCs (10 (5.6 %) for both groups) but DC
dysfunction was more frequent with GWE-DCs (67 (37.6 %) vs. 28 (15.7 %); hazard ratio (HR), 3.67 (2.07–6.49); p < 0.01).
Results were similar if analysis was restricted to DCs changed for dysfunction.
Conclusions: GWE for DCs in ICU patients, compared with VPI did not contribute to DC colonization or infection but
was associated with more than twofold increase in DC dysfunction.
Trial registration: This study is registered with ClinicalTrials.gov, number NCT00563342. Registered 2 April 2009.
Keywords: Acute kidney injury (AKI), Catheter-related infection, Double lumen vascular catheter, Guidewire exchange
versus new venipuncture, Catheter dysfunction, Intensive care unit
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Background
Acute kidney injury (AKI) predisposes to end-stage renal
disease (ESRD) [1, 2], and the preservation of the vascu-
lar network in the event of subsequent chronic dialysis is
of foremost importance and may be challenging when
short-term dialysis catheter (DC) placement is required
for the provision of renal replacement therapy (RRT).
DCs are often removed because of suspected infection
or dysfunction [3–13].
DC replacement is classically carried out by de novo
percutaneous venipuncture insertion (VPI) but is not al-
ways achievable in cases of obesity, thrombocytopoenia,
coagulopathy and extensive burns. In addition, VPI may
compromise future vascular access. Guidewire exchange
(GWE) is an alternative approach for easily changing
DCs and has a lower risk of mechanical complications
than VPI at new sites. However, GWE may predispose to
infectious complications and is therefore discouraged in
central venous catheterization [14].
In patients with chronic haemodialysis who need DC re-
placement, GWE may be appropriate when other insertion
sites are not available or when the risk of a new
venipuncture exceeds the benefit of DC removal [15]. This
recommendation is for patients with long-term DCs and
may not be applicable to critically ill patients on RRT. Of
note, Kidney Disease Improving Global Outcome (KDIGO)
practice guidelines for AKI provide no information on DC
placement by GWE [16]. Of the numerous studies that
have recently assessed DC infection in acutely ill patients
[3–13, 17] only one, with a small sample size population,
looked at the risk of infectious complications following
GWE and did not deal with DC dysfunction [12].
We designed a post-hoc cohort study to compare the
risk of DC colonization and DC dysfunction after inser-
tion at a new site or GWE. We used data collected pro-
spectively during a randomized controlled trial (Ethanol
lock and risk of hemodialysis catheter infection in critic-
ally ill patients (ELVIS): ClinicalTrial.gov Registration
NCT 00875069) [13].
Method
Study patients
The ELVIS trial was a multicentre, randomized, double
blind, placebo-controlled, parallel- group study of 1460
critically ill adults from 16 ICUs, who required a tempor-
ary DC, which showed that a 2-minute ethanol lock does
not decrease the frequency of DC infection [13]. The
Sud-Est 1 ethics committee, France, approved the study
protocol (IRB 00008526). Written informed consent was
obtained from all the participants or their proxies.
Study catheters
All DCs were non-tunnelled, non-antimicrobial-
impregnated, double-lumen temporary catheters that were
only used for RRT or plasma exchange (PE). The site of
DC placement, the use of ultrasound guidance for DC in-
sertion, and the decision to replace DCs by VPI or by
GWE was at the discretion of operator. The GWE proced-
ure was adapted from Seldinger’s technique (Additional
file 1). The procedure for DC insertion and manipulation
is described in Additional file 2. At DC removal, DC tips
were cultured using a simplified quantitative broth dilu-
tion technique with vortexing or sonication. In patients
who kept the DC after ICU discharge, paired blood sam-
ples were drawn simultaneously from the DC hub and a
peripheral vein before discharge to determine the differen-
tial time to positivity.
Definitions
DC-tip colonization, catheter-related bloodstream infec-
tion (CRBSI) and DC dysfunction were defined accord-
ing to French and American guidelines [14, 18].
Study design
The study included two different cohort analyses. In the
first study, we compared DC colonization and dysfunc-
tion in patients with or without GWE for DC placement.
In patients with multiple DC placements by GWE, only
the first DC inserted by GWE was taken into account.
The patients were selected by a matched-cohort ap-
proach, and matching was performed with replacement.
Matching criteria were selected to exclude other factors
that could influence catheter infection or dysfunction:
severity of illness scoring by simplified acute physiology
score (SAPS) II +/-10; insertion site for femoral place-
ment; insertion site and side position for internal jugular
placement and duration between ICU admission and DC
placement (+/- 2 days for DC inserted <7 days, +/- 5 days
for DC inserted from 7 to 15 days, +/- 7 days for DC
inserted from 15 to 21 days, +/- 10 days for DC inserted
>21 days). As GWE is mostly performed to replace a
malfunctioning DC, a second analysis was conducted to
compare the rate of DC dysfunctions in new placements
by GWE and by VPI in patients from the ELVIS cohort
who had consecutive DC placements after the old DC
had been removed for dysfunction, regardless of place-
ment technique.
Statistical analysis
Continuous and categorical variables were expressed as
number and percentage or as median and interquartile
range, respectively. Comparisons were performed by non-
parametric (Mann-Whitney) and chi-square tests as ap-
propriate. In the matched-cohort population, the effect of
the strategy of DC insertion (GWE vs. VPI) on colo-
nization and on DC dysfunction was estimated with a
marginal Cox model, controlling for differences between
groups before DC insertion and at DC insertion, selected
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by stepwise analysis. The statistical unit was the DC. Stat-
istical analyses were performed with SAS statistical soft-
ware, version 9.3 (SAS Institute Inc., Cary, NC, USA) and
R statistical software, version 2.12.1 (R Foundation for
Statistical Computing, Vienna, Austria). A p value <0.05
was considered significant.
Results
Results of the matched-cohort analysis
Of the 2172 DCs recorded in the ELVIS database and used
for the intention-to-treat analysis, 272 were inserted by
GWE in 205 patients. Of these, 178 could be matched
with controls according to the matching criteria and were
therefore used as cases. The 178 controls were identified
from 150 DCs in 143 patients in the database (matching
with replacement). The characteristics of the patients and
DCs are given in Tables 1 and 2. In the GWE group, the
reason for prior catheter removal was known in 107 cases,
and the reason was dysfunction in 97 cases and suspected
infection in 10 cases. In the VPI group, 48 DCs were re-
placement catheters. The reason for catheter removal was
Table 1 Characteristics of patients in the matched cohort
GWE VPI P value
(n = 178) (n = 178)
Age, years, median (IQR) 63 (55–73) 67 (56–78) 0.05
Male, n (%) 118 (66.3) 92 (64.3)
BMI, median (IQR) 27.2 (22.9–31.6) 27.1 (24.2–29.7) 0.61
Immunocompromised, n (%) 40 (22.5) 36 (20.2) 0.60
Main reason for ICU admission, n (%)
Septic shock 54 (30.3) 55 (30.9) 0.91
Other shock 21 (11.8) 26 (14.6) 0.43
Coma 13 (7.3) 13 (7.3) 1.00
Acute respiratory failure 38 (21.3) 51 (28.7) 0.11
Acute renal failure 28 (15.7) 16 (9) 0.05
SAPS II, median (IQR) 66 (53–84) 66 (54–81) 0.99
SOFA score, median (IQR) 18 (14-21) 18 (15-20) 0.77
Invasive MV, n (%) 47 (26.4) 51 (28.7) 0.64
NIV, n (%) 14 (7.9) 11 (6.2) 0.53
DCs/patient, median (IQR) 2.5 (2-3) 1 (1-2) <0.01
Type of sessions, median (IQR)
Number of PE sessions 0 (0–0) 0 (0–0) -
Number of RRT sessions 7.5 (4–14) 4 (2–9) <0.01
Number of IHD, sessions 3 (1–8) 2 (0–5) <0.01
Number of CRRT days 2 (0–6) 1 (0–3) <0.01
Length of stay, median (IQR)
ICU 19 (11–32) 17 (8–25) 0.04
Hospital 37.5 (21–61) 32.5 (15–54) 0.02
ICU mortality, n (%) 68 (38.2) 77 (43.3) 0.33
Hospital mortality, n (%) 81 (45.5) 87 (48.9) 0.52
BMI body mass index, GWE guidewire exchange, ICU intensive care unit, IQR
interquartile range, CRRT continuous renal replacement therapy, IHD intermittent
haemodialysis, MV invasive mechanical ventilation, NIV non-invasive ventilation,
PE plasma exchange, SAPS simplified acute physiology score, SOFA sequential
organ failure assessment, VPI venipuncture insertion
Table 2 Characteristics of dialysis catheters in the matched
cohort
GWE VPI P value
(n = 178) (n = 178)
Days from ICU admission
to DC placement, median (IQR) 4 (2–10) 3.5 (1–9) 0.03
MV at DC insertion, n (%) 134 (75.3) 133 (74.7) 0.90
Catecholamine at DC insertion, n (%) 104 (58.4) 117 (65.7) 0.16
Presence of another catheter
at the time of insertion, n (%) 169 (94.9) 166 (93.3) 0.5
First DC placement, n (%) 39 (21.9) 130 (73) <0.01
Rank of DC placement, median (IQR) 2 (2–2) 1 (1–2) <0.01
Insertion site, n (%)
Internal jugular 49 (27.5) 49 (27.5) 1.00
Femoral 129 (72.5) 129 (72.5) 1.00
Right side 110 (61.8) 113 (63.8) 0.74
Experience of the operator
<50 procedures, n (%) 135 (75.8) 127 (71.8) 0.18
Alcohol-based skin antiseptic solution, n (%)
5 % povidone-iodine, 70 % ethanol 82 (46.1) 79 (44.4) 0.75
0.5 % chlorhexidine, 67 % ethanol 93 (52.2) 95 (53.4) 0.83
Systemic antimicrobials
at catheter insertion, n (%) 149 (83.7) 151 (84.8) 0.77
DC use, n (%)
No RRT/PE performed 7 (3.9) 8 (4.5) -
PE only 9 (5.1) 6 (3.4) -
RRT only 158 (88.8) 164 (92.1) 0.19
Both PE/RRT 4 (2.2) 0 (0) -
Reason for DC removal, n (%)
DC dysfunction 67 (37.6) 28 (15.7) <0.01
Suspected DC infection 20 (11.2) 14 (7.9) -
DC no longer needed 40 (22.5) 58 (32.6) -
Death of the patient 28 (15.7) 50 (28.1) -
Other reasons 23 (12.9) 28 (15.7) -
DC use duration, days, median (IQR) 4 (2–7) 5 (2–8) <0.01
DC days, n 922 937
DC tip culture performed at
removal, n (%)
154 (86.5) 140 (78.7)
DC-related colonization, n (%) 10 (5.6) 10 (5.6) 1.00
DC dialysis catheter, GWE guidewire exchange, ICU intensive care unit, IQR
interquartile range, CRRT continuous renal replacement therapy, IHD
intermittent haemodialysis, MV invasive mechanical ventilation, NIV non-invasive
ventilation, PE plasma exchange, RRT renal replacement therapy, SAPS simplified
acute physiology score, SOFA sequential organ failure assessment, VPI
venipuncture insertion
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known in only nine cases, and this was dysfunction in
eight cases and suspected infection in the other.
The time from admission to DC insertion was shorter in
the VPI group than in the GWE group (p = 0.03). DCs
were mainly inserted on the day of inclusion in the ELVIS
study (p < 0.01), and DC stay was longer (p < 0.01).
Infection
The DC colonization rate was 5.6 % (10 events) in both
groups. After adjustment for baseline differences between
groups, ICU stay before insertion and first DC placement
were not associated with colonization (weighted hazard
ratio (HR) 1.33, 95 % CI 0.57, 3.12; p = 0.51 for ICU stay
before insertion and weighted HR 4.71, 95 % CI 0.03,
647.07; p = 0.51 for the first DC placement). As shown in
Fig. 1, GWE was not associated with an increased risk of
colonization (10.85 vs. 10.67 per 1000 catheter-days;
weighted HR 4.11, 95 % CI 0.14, 122.32; p = 0.41). The
aetiologic organisms of DC colonization are shown in
Table 3. CRBSI was identified in three cases, two in the
GWE group and one in the VPI group.
Dysfunction
The dysfunction rate was 37.6 % in the GWE group (67
events), and 15.7 % (28 events) in the VPI group
(weighted HR 3.67, 95 % CI 2.07, 6.49; p < 0.01). After
adjustment for baseline differences between groups, ICU
stay before insertion and first DC placement were not
associated with dysfunction (weighted HR 0.86, 95 % CI
0.70, 1.05; p = 0.14 for ICU stay before insertion and
weighted HR 0.50, 95 % CI 0.18, 1.34; p = 0.16 for the
first DC placement). As shown in Fig. 2, GWE led to a
significant increase in the risk of dysfunction (72.7 vs.
22.4 per 1000 catheter-days; weighted HR 3.56, 95 % CI
1.66, 7.63; p < 0.001).
Results of the cohort study on sequential DC
replacements for malfunctioning DCs
Consecutive dialysis catheterizations with the old DC re-
moved for dysfunction were identified in 301 cases
(Additional file 3). The DC dysfunction rate was 49.7 %
(80 events, 94.9 per 1000 catheter-days) for new DCs
inserted by GWE and 27.9 % (39 events, 36.3 per 1,000
catheter-days) for new DCs inserted by VPI (HR 2.40,
95 % CI 1.66, 3.47; p < 0.0001).
After adjustment for side placement and insertion site,
dysfunction of new DCs inserted was associated with
placement by GWE and placement on the left side but not
with insertion site (femoral vs. internal jugular) (Additional
file 4).
Discussion
In this secondary analysis of the ELVIS study, we found
that inserting a DC by GWE (as opposed to VPI) did
not increase the risk of DC colonization but was associ-
ated with a higher risk of DC dysfunction. The risk of
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Fig. 1 Overall Kaplan-Meier curve of time to dialysis catheter colonization at removal. GWE guidewire exchange, VPI venipuncture insertion
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DC dysfunction was more than twofold higher when the
previous DC was malfunctioning and had been replaced
by GWE rather than by VPI.
In a pilot study Palmer et al. demonstrated that guide-
wire contamination during central line placement predis-
poses to subsequent colonization of the inserted catheter
[19]. This is why replacement by GWE of a non-tunnelled
catheter that is suspected to be infected is discouraged,
but it may be used to replace a malfunctioning catheter
when there is no evidence of catheter infection [14].
Three recent observational studies of critically ill adult
patients, designed to assess the impact of catheter re-
placement by GWE on the risk of infections, yielded
conflicting results [20–22]. In a prospective multicentre
survey of 1598 central venous catheters, including 67
inserted by GWE, GWE was identified as an independ-
ent risk factor of catheter-related bacteraemia; however,
more than 20 % of the catheters were inserted outside of
the ICU [23]. Conversely, two single-centre observa-
tional studies, including one that examined triple-lumen
antimicrobial surface-treated catheters [22], reported that
the rate of catheter colonization in serial catheter inser-
tions was not influenced by GWE [20, 22]. However,
whether the results of these studies can be applied to DC
placement by GWE is questionable because central ven-
ous catheters and DCs are inserted for different purposes
and their extent and manner of use are not the same, and
critically ill patients with AKI requiring RRT have a higher
mortality rate than the general ICU population.
DC replacement by GWE may have several theoretical
advantages over VPI. First, inserting DCs by the blind
anatomical landmark technique risks arterial puncture
and other mechanical complications [8]. Ultrasound-
guided catheterization reduces but does not eradicate
these risks, while GWE eliminates puncture-related com-
plications. Second, using a new site may compromise the
vascular network. Third, GWE may be the last option
when no alternative insertion sites other than subclavian
Table 3 Distribution of the microorganisms involved in dialysis
catheter colonization
Aetiologic microorganisms GWE VPI
Colonized DC N = 10 N = 10
Gram-positive
Staphylococcus aureus 0 1
Staphylococcus epidermidis 4 0
Other coagulase-negative Staphylococci 2 7
Enterococcus species 0 1
Other Gram-positive 1 0
Gram-negative
Escherichia coli 1 0
Klebsiella pneumonia 0 1
Fungi 2 1
DC dialysis catheter, GWE guidewire exchange, VPI venipuncture insertion
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Fig. 2 Overall Kaplan-Meier curve of time to dialysis catheter dysfunction at removal. GWE guidewire exchange, VPI venipuncture insertion
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sites are available. There is a paucity of information on the
impact of DC placement by GWE on DC colonization in
critically ill patients. In a recently published study, no dif-
ference in the risk of DC colonization between GWE and
VPI was found in 96 patients with initial femoral DC in-
sertion, who underwent serial DC placement by GWE (53
DCs) or VPI (100 DCs) [12].
Our study differed in the severity of illness among the
patients, the systematic culture of DC tip at DC removal
and the bacteriological method used for defining DC
colonization, but it yielded similar results. Our study
also provides new data by including both patients with
non-femoral dialysis catheterization and patients receiv-
ing intermittent haemodialysis.
The choice between GWE and VPI in critically ill pa-
tients requiring RRT for DC replacement should also be
influenced by the risk of DC dysfunction. Most defini-
tions and studies of DC dysfunction were developed for
and conducted in patients with ESRD on intermittent
haemodialysis and are difficult to apply to critically ill
patients [23]. Data on DC dysfunction in the ICU setting
are scarce [9, 10, 17, 24]. Comparison of these studies is
difficult because of differences in populations, tech-
niques used for RRT, type of interdialytic DC locks and
definitions of dysfunction [25]. The rates of DC dysfunc-
tion observed in our study in the VPI group, both in the
main analysis (14 %) and in the second analysis that
dealt specifically with patients with serial DC replace-
ments (27.1 %), were in agreement with those published
in a study using DC removal to define dysfunction (10 %
for first DC placements and 24 % for subsequent place-
ments at a new site) [10].
To the best of our knowledge, this study is the first to
assess the risk of DC dysfunction when DCs are placed
by GWE rather than by VPI in the ICU setting. Several
characteristics may predispose to DC dysfunction such
as catheter material [26], length [10], gauge [27], inser-
tion site [10] and blood flow velocity through the DC
[10]. In the ELVIS study the DC characteristics and
causes of DC dysfunctions were not recorded, which re-
stricted our ability to elaborate on the mechanisms in-
volved. However, in each centre only one DC brand and
one type of DC material were used. Furthermore, in ac-
cordance with local standard practice, almost all internal
jugular DCs placed on the right side were 16 cm long
and almost all femoral DCs were at least 20 cm long. As
controls and cases were matched by centre and insertion
site, this suggests that in our study DC characteristics
had only a marginal impact on the observed difference
in dysfunction rates between VPI and GWE. We specu-
late that replacing malfunctioning DCs by GWE rather
than by VPI more often fails to resolve dysfunction when
dysfunction results from incorrect tip location or pro-
gressive occlusion of the DC lumen by thrombus.
Our results are in agreement with those of the Cathedia
study, which reported that jugular site placement did not
outperform femoral site for dysfunction of short-term
DCs in the ICU. However, in the Cathedia cohort left-
jugular DC insertion conferred a higher risk of dys-
function than other placements [10], whereas in our study
left-side insertion in both jugular and femoral positions
predisposed to DC dysfunction, probably because it in-
volves a less direct route to the superior vena cava. In our
study, DCs were inserted in the femoral site in more than
70 % of cases and mainly on the right side. We cannot ex-
clude that 20-cm-long DCs placed at the left femoral site
may not be long enough to allow their tips to extend to
the inferior vena cava, contributing to the observed
greater risk of dysfunction.
Limitations
Our work has certain limitations. First, the choice as to
whether to perform a GWE or a VPI was at the discre-
tion of the treating physician, and the reasons for the
choice were not recorded in the ELVIS database. Thus,
no specific adjustment could be performed to take into
account these criteria. In our study, in accordance with
recommended guidelines [14], GWE was rarely per-
formed for replacement of a DC with suspected infec-
tion. Second, as a non-randomized study, it is potentially
subject to bias in patient selection. However, the results
were probably not affected because of the matched-
control approach, which balanced the main risk factors
for DC colonization between both groups. Third, we
cannot exclude the possibility that we failed to detect an
increased risk in DC colonization after GWE because
the study did not have sufficient power. However, the
sample size in this secondary analysis of the ELVIS study
was substantially larger than that of the previously pub-
lished study, which found similar results. Fourth, includ-
ing initial DC insertion in the control group may have
biased the study against cases. However, several studies
suggest the risk of infectious complication is not influ-
enced by initial or subsequent catheterizations but rather
by catheter dwell time and longer ICU stay [12, 20]. The
putative bias related to initial DC placement had prob-
ably only a marginal impact on our results on DC
colonization, as controls were adjusted to cases accord-
ing to ICU stay before DC insertion. In addition, the
sensitivity analyses were limited to serial catheterization
and yielded similar results. Fifth, the primary endpoint
of the study was not CRBSI, which may limit the clinical
relevance of our work. However, the use of catheter-tip
colonization as a surrogate endpoint for the most severe
forms of catheter infection has been widely documented
elsewhere [28]. Sixth, our results do not apply to pa-
tients with ESRD in dialysis units or to long-term
catheterizations.
Coupez et al. Critical Care  (2016) 20:230 Page 6 of 8
Conclusion
In ICU patients requiring DC replacement, GWE does
not present a significant risk factor for DC-related
colonization/infection but predisposes to dysfunction. It
would now be opportune to carry out a randomized
controlled study to confirm that GWE could be an ac-
ceptable alternative to reinsertion at a different site for
preserving the vascular network, particularly in patients
with difficult venous access.
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Additional file 2: GWE technique for DC placement. (DOC 23 kb)
Additional file 3: Follow up of DCs inserted by GWE or by VPI at a new
site to replace a previous one removed for dysfunction. (DOCX 26 kb)
Additional file 4: Factors associated with DC colonization in the 38
pairs of consecutive DC placements when the first DC was colonized at
removal. (DOCX 15 kb)
Abbreviations
AKI, acute kidney injury; CRBSI, catheter-related bloodstream infection; DC,
dialysis catheter; ESRD, end-stage renal disease; GWE, guidewire exchange;
HR, hazard ratio; KDIGO, Kidney Disease Improving Global Outcome; PE,
plasma exchange; RRT, renal replacement therapy; SAPS, simplified acute
physiology score; SOFA, sequential organ failure assessment; VPI,
venipuncture insertion
Acknowledgements
This study was supported by Grants from the French Ministry of Health
(Programme Hospitalier de Recherche Clinique National 2008 “ELVIS” and
Programme Hospitalier de Recherche Clinique Inter-régional 2009 “ESCAPE”).
We thank J. Watts for assistance in preparing and reviewing the manuscript.
We thank Dr A. AitHssain (Medical-Intensive Care Unit, University Hospital,
Clermont-Ferrand, France), Drs O. Martin, M. Cour and T.N. Phan (Medical-
Intensive Care Unit, University Hospital, Lyon, France), Dr G. Hilbert (Medical-
Intensive Care Unit, University Hospital, Bordeaux, France), Dr F. Zéni
(Medical-Intensive Care Unit, University Hospital, Saint Etienne, France),
Dr J.M. Constantin (Department of Anaesthesiology and Critical Care Medicine,
University Hospital, Clermont-Ferrand, France), Dr M. Mehdi (Nephrology and
Critical care Unit, University Hospital, Saint Etienne, France), Dr L. Rostaing
(Nephrology and Critical care Unit, University Hospital, Toulouse, France), Drs M.
Wolff and Y. Cohen (Medical-Intensive Care Unit, University Hospital, Paris,
France), Dr B. Misset (Medical-Intensive Care Unit, Paris, France) for acquisition of
data and administrative support. We thank S. Calvino (RN, Medical-Intensive
Care Unit, University Hospital, Grenoble, France) for acquisition of data and
administrative support. We thank Drs O. Traoré and C. Aumeran (Department of
infection control and prevention, University Hospital, Clermont-Ferrand, France)
for their helpful comments during the preparation of the study. We thank
clinical research assistants: E. Guilhon (Bordeaux), D. Morand (Clermont-Ferrand),
N. Caillot (Clermont-Ferrand), A. Daniel (Grenoble), M. Provent, H. Thizy, S. Vizoso
and S. Conrozier (Lyon), A. Rodriguez (Montpellier), S. Letrou, M. Kaoutard and
L.M. Laisne (Paris), A. Schmied and S. Aberrane (Saint Etienne) for acquisition of
data. We are grateful to all medical staff, staff nurses in the 16 sites, who
strongly contributed to the success of the study.
Funding
This study was supported by Grants from the French Ministry of Health
(Programme Hospitalier de Recherche Clinique National 2008 “ELVIS” and
Programme Hospitalier de Recherche Clinique Inter-régional 2009 “ESCAPE”).
Availability of data and materials
The data sets supporting the results of this article are available on request
that may be addressed to bsouweine@chu-clermontferrand.fr.
Authors’ contributions
Study concept and design: EC, BS, AL, NC and JFT. Acquisition of data: BS,
AL, LB, CS, DG, AB, KK, EC, LA, AL, JB, FV, MG-O, SC, CM, OC and JFT. Analysis
and interpretation of data: EC, BS, AL and JFT. Drafting of the manuscript: EC,
BS, AL and JFT. Critical revision of the manuscript for important intellectual
content: EC, BS, AL, JFT, LB, CS, DG, AB, KK, EC, LA, AL, JB, FV, MG-O, SC, CM
and OC. Statistical analysis: SR and JFT. Administrative, technical or material
support: BS, AL, NC and JFT. Study supervision: BS, AL, NC and JFT. All authors
read and approved the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Consent for publication
All authors consent to publication of the revised manuscript.
Ethics approval and consent to participate
The Sud-Est 1 ethics committee, France, approved the study protocol (IRB
00008526). Written informed consent was obtained from all the participants
or their proxies.
Author details
1Medical Intensive Care Unit, University Hospital of Clermont-Ferrand, 58 rue
Montalembert, 63000 Clermont-Ferrand, France. 2IAME UMR 1137 Inserm
Université Paris Diderot, Paris F-75018, France. 3Medical and Infectious
Diseases ICU -Paris Diderot University / Bichat Hospital, Paris, France. 4U823
“Outcome of Cancers and Critical Illness,” Albert Bonniot Institute, La
Tronche, France. 5Medical Intensive Care Unit, Pellegrin Teaching Hospital,
University Hospital of Bordeaux, Bordeaux, France. 6Medical Intensive Care
Unit, Saint Louis Teaching Hospital, Paris, France. 7Medical Intensive Care
Unit, Lapeyronie Teaching Hospital, University Hospital of Montpellier,
Montpellier, France. 8Medical Intensive Care Unit, Edouard Herriot Teaching
Hospital, University of Lyon, Lyon, France. 9Medical Intensive Care Unit,
University Hospital of Lyon, Lyon, France. 10Critical Care Medicine Unit,
Saint-Joseph Hospital, Paris, France. 11Nephrology and Critical Care Unit,
Nord Teaching Hospital, University of Saint Etienne, Saint Etienne, France.
12Medical Intensive Care Unit, Avicenne Teaching Hospital, Paris, France.
13Department of Anaesthesiology and Critical Care Medicine, University
Hospital of Clermont-Ferrand, Clermont-Ferrand, France. 14Nephrology and
Critical Care Medicine, Rangueil Teaching Hospital, University of Toulouse,
Toulouse, France. 15Department of Anaesthesiology and Critical Care
Medicine Pierre Benite Teaching Hospital, University Hospital of Lyon, Lyon,
France. 16Medical Intensive Care Unit, Nord Teaching Hospital, University of
Saint Etienne, Saint Etienne, France. 17Medical Intensive Care Unit,
Bichat-Claude Bernard Teaching Hospital, Paris, France.
Received: 12 April 2016 Accepted: 1 July 2016
References
1. Coca SG, Singanamala S, Parikh CR, et al. Chronic kidney disease after acute
kidney injury: a systematic review and meta-analysis. Kidney Int.
2012;81:442–8.
2. Rimes-Stigare C, Frumento P, Bottai M, et al. Evolution of chronic renal
impairment and long-term mortality after de novo acute kidney injury in
the critically ill; a Swedish multi-centre cohort study. Crit Care Lond Engl.
2015;19:221.
3. Souweine B, Traore O, Aublet-Cuvelier B, et al. Dialysis and central venous
catheter infections in critically ill patients: results of a prospective study. Crit
Care Med. 1999;27:2394–8.
4. Chatzinikolaou I, Finkel K, Hanna H, et al. Antibiotic-coated hemodialysis
catheters for the prevention of vascular catheter-related infections: a
prospective, randomized study. Am J Med. 2003;115:352–7.
5. Harb A, Estphan G, Nitenberg G, et al. Indwelling time and risk of infection
of dialysis catheters in critically ill cancer patients. Intensive Care Med.
2005;31:812–7.
6. Souweine B, Liotier J, Heng AE, et al. Catheter colonization in acute renal
failure patients: comparison of central venous and dialysis catheters. Am J
Kidney Dis. 2006;47:879–87.
Coupez et al. Critical Care  (2016) 20:230 Page 7 of 8
7. Klouche K, Amigues L, Deleuze S, et al. Complications, effects on dialysis
dose, and survival of tunneled femoral dialysis catheters in acute renal
failure. Am J Kidney Dis. 2007;49:99–108.
8. Parienti J-J, Thirion M, Mégarbane B, et al. Members of the Cathedia Study
Group: Femoral vs jugular venous catheterization and risk of nosocomial
events in adults requiring acute renal replacement therapy: a randomized
controlled trial. JAMA. 2008;299:2413–22.
9. Skofic N, Buturović-Ponikvar J, Kovac J, et al. Hemodialysis catheters with citrate
locking in critically ill patients with acute kidney injury treated with intermittent
online hemofiltration or hemodialysis. Ther Apher Dial. 2009;13:327–33.
10. Parienti J-J, Mégarbane B, Fischer M-O, et al. Cathedia Study Group: Catheter
dysfunction and dialysis performance according to vascular access among
736 critically ill adults requiring renal replacement therapy: a randomized
controlled study. Crit Care Med. 2010;38:1118–25.
11. Parienti J-J, Dugué AE, Daurel C, et al. Members of the Cathedia Study
Group: Continuous renal replacement therapy may increase the risk of
catheter infection. Clin J Am Soc Nephrol CJASN. 2010;5:1489–96.
12. Chua H-R, Schneider AG, Sherry NL, et al. Initial and extended use of
femoral versus nonfemoral double-lumen vascular catheters and catheter-
related infection during continuous renal replacement therapy. Am J Kidney
Dis. 2014;64:909–17.
13. Souweine B, Lautrette A, Gruson D, et al. Ethanol lock and risk of
hemodialysis catheter infection in critically ill patients. A randomized
controlled trial. Am J Respir Crit Care Med. 2015;191:1024–32.
14. O’Grady NP, Alexander M, Burns LA, et al. Healthcare Infection Control
Practices Advisory Committee: Guidelines for the prevention of intravascular
catheter-related infections. Am J Infect Control. 2011;39:S1–34.
15. Goldsmith DJA, Covic A, Fouque D, et al. Endorsement of the Kidney Disease
Improving Global Outcomes (KDIGO) Chronic Kidney Disease-Mineral and
Bone Disorder (CKD-MBD) Guidelines: a European Renal Best Practice (ERBP)
commentary statement. Nephrol Dial Transplant. 2010;25:3823–31.
16. Okusa MD, Davenport A. Reading between the (guide)lines–the KDIGO
practice guideline on acute kidney injury in the individual patient. Kidney
Int. 2014;85:39–48.
17. Hermite L, Quenot J-P, Nadji A, et al. Sodium citrate versus saline catheter
locks for non-tunneled hemodialysis central venous catheters in critically ill
adults: a randomized controlled trial. Intensive Care Med. 2012;38:279–85.
18. Mermel LA, Farr BM, Sherertz RJ, et al. Infectious Diseases Society of
America, American College of Critical Care Medicine, Society for Healthcare
Epidemiology of America: Guidelines for the management of intravascular
catheter-related infections. Clin Infect Dis. 2001;32:1249–72.
19. Palmer S, Solano T. Contamination of guidewires during insertion of central
venous catheters in an intensive care setting. Infect Control Hosp
Epidemiol. 2005;26:506–7.
20. Castelli GP, Pognani C, Stuani A, et al. Central venous catheter replacement
in the ICU: new site versus guidewire exchange. Minerva Anestesiol.
2007;73:267–73.
21. Garnacho-Montero J, Aldabó-Pallás T, Palomar-Martínez M, et al. Risk factors
and prognosis of catheter-related bloodstream infection in critically ill
patients: a multicenter study. Intensive Care Med. 2008;34:2185–93.
22. Parbat N, Sherry N, Bellomo R, et al. The microbiological and clinical
outcome of guide wire exchanged versus newly inserted antimicrobial
surface treated central venous catheters. Crit Care Lond Engl. 2013;17:R184.
23. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic
kidney disease: evaluation, classification, and stratification. Am J Kidney Dis.
2002;39:S1–266.
24. Hryszko T, Brzosko S, Mazerska M, et al. Risk factors of nontunneled
noncuffed hemodialysis catheter malfunction. A prospective study. Nephron
Clin Pract. 2004;96:c43–7.
25. Mrozek N, Lautrette A, Timsit J-F, Souweine B. How to deal with dialysis
catheters in the ICU setting. Ann Intensive Care. 2012;2:48.
26. Joannidis M, Oudemans-van Straaten HM. Clinical review: Patency of the circuit
in continuous renal replacement therapy. Crit Care Lond Engl. 2007;11(4):218.
27. Bellomo R, Mårtensson J, Lo S, Kaukonen K-M, Cass A, Gallagher M, RENAL
study investigators and the Australian and New Zealand Intensive Care
Clinical Trials Group. Femoral Access and Delivery of Continuous Renal
Replacement Therapy Dose. Blood Purif. 2016;41(1-3):11–7.
28. Rijnders BJA, Van Wijngaerden E, Peetermans WE. Catheter-tip colonization
as a surrogate end point in clinical studies on catheter-related bloodstream
infection: how strong is the evidence? Clin Infect Dis. 2002;35:1053–8.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Coupez et al. Critical Care  (2016) 20:230 Page 8 of 8
